Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
level increased » levels increased (Expand Search), levels decreased (Expand Search), gene increased (Expand Search)
Showing 221 - 240 results of 36,050 for search '(( significantly ((level increased) OR (mean decrease)) ) OR ( significant decrease decrease ))', query time: 0.51s Refine Results
  1. 221
    Why does task performance decrease with burst length?

    Why does task performance decrease with burst length? by Swathi Anil (17382903)

    Published 2025
    Save to List
    Saved in:
  2. 222
    Mean KAP scores and standard deviation at different assessment times.

    Mean KAP scores and standard deviation at different assessment times. by Chikondi Maluwa (20660522)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 223
    Means, standard deviations, and inferential statistics for the outcomes in the three conditions tested.

    Means, standard deviations, and inferential statistics for the outcomes in the three conditions tested. by Robert Trybulski (10998702)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 224
    RTL8 incorporates into PEG10 VLPs and decreases the efficiency of release.

    RTL8 incorporates into PEG10 VLPs and decreases the efficiency of release. by Will Campodonico (20485651)

    Published 2024
    Save to List
    Saved in:
  5. 225
    Relevant follow-up evaluation indicators after operation (mean±standard deviation)/n (%).

    Relevant follow-up evaluation indicators after operation (mean±standard deviation)/n (%). by Na Wang (193263)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  6. 226
    Minimal data set.

    Minimal data set. by Pornpan Chalermkitpanit (22110121)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 227
    Univariate and multivariate analysis of variables associated with good and poor responders to TFESI.

    Univariate and multivariate analysis of variables associated with good and poor responders to TFESI. by Pornpan Chalermkitpanit (22110121)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 228
    The correlation between clinical presentations and baseline serum inflammatory cytokines before TFESI.

    The correlation between clinical presentations and baseline serum inflammatory cytokines before TFESI. by Pornpan Chalermkitpanit (22110121)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 229
    The serum concentrations of cytokines between good responders and poor responders to TFESI.

    The serum concentrations of cytokines between good responders and poor responders to TFESI. by Pornpan Chalermkitpanit (22110121)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 230
    Demographic data and baseline characteristics between good and poor responders to TFESI.

    Demographic data and baseline characteristics between good and poor responders to TFESI. by Pornpan Chalermkitpanit (22110121)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 231
    Supplementary results_detailed.

    Supplementary results_detailed. by Pornpan Chalermkitpanit (22110121)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 232
    Summary of post-treatment disease course measures from MDMA-AT publications.

    Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 233
    Study selection criteria.

    Study selection criteria. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 234
    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.

    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 235
    Disease course measures after the PTSD treatments.

    Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 236
    PICOS criteria for the SLR.

    PICOS criteria for the SLR. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 237
    Summary of post-treatment CAPS score changes from MDMA-AT publications.

    Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 238
    Summary of post-treatment disease course measures from off-label medications clinical trials.

    Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 239
    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.

    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 240
    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.

    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: